| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7ef01e33058cf740cf2197991be97af1 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
1997-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44e05c8d3aedda8a9ea6044a64808648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2748b786cac11eb3d7d14bfd9504ce6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208916047f78174e00ec432318ba1f7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a00fba853333525ea87eefb85cccd319 |
| publicationDate |
1999-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H11171886-A |
| titleOfInvention |
Pyrrolylbenzimidazole derivatives having amidine or guanidine in the side chain |
| abstract |
(57) [Problem] To create a novel substance which acts on DNA and is used as an anticancer agent. SOLUTION: The compound represented by the general formula 1 or 2 or a pharmacologically acceptable salt. [Effect] The above compounds are used as anticancer agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7498349-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017528520-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6716866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7642245-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11059836-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7129214-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6559125-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7265129-B2 |
| priorityDate |
1997-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |